Non-Hodgkin's lymphoma presenting as a pelvic mass with elevated CA-125
- 1 September 2004
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (3) , 811-813
- https://doi.org/10.1016/j.ygyno.2004.05.057
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The prognostic significance of CA 125 in patients with non‐Hodgkin's lymphomaEuropean Journal of Haematology, 2002
- SERUM CA 125 LEVELS IN CHILDREN WITH NON-HODGKIN'S LYMPHOMAPediatric Hematology and Oncology, 1999
- Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphomaCancer, 1998
- CA 125 Elevations in Patients with Malignant LymphomasTumor Biology, 1998
- CA-125: a tumor marker in non-Hodgkin's lymphomas?Journal of Clinical Oncology, 1995
- NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian CancerJAMA, 1995
- CA-125 in primary mediastinal B-cell lymphoma with sclerosis.Journal of Clinical Oncology, 1995
- The Role of Serum Tetranectin, CA 125, and a Combined Index as Tumor Markers in Women with Pelvic TumorsGynecologic Oncology, 1995
- CA 125 secretion by peritoneal mesothelial cells.Journal of Clinical Pathology, 1994
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983